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AbstrACt
Objectives To develop a dynamic prediction model for 
high blood pressure at the age of 9–10 years that could be 
applied at any age between birth and the age of 6 years in 
community-based child healthcare.
Design, setting and participants Data were used from 
5359 children in a population-based prospective cohort 
study in Rotterdam, the Netherlands.
Outcome measure High blood pressure was defined as 
systolic and/or diastolic blood pressure ≥95th percentile 
for gender, age and height. Using multivariable pooled 
logistic regression, the predictive value of characteristics 
at birth, and of longitudinal information on the body 
mass index (BMI) of the child until the age of 6 years, 
was assessed. Internal validation was performed using 
bootstrapping.
results 227 children (4.2%) had high blood pressure 
at the age of 9–10 years. Final predictors were maternal 
hypertensive disease during pregnancy, maternal 
educational level, maternal prepregnancy BMI, child 
ethnicity, birth weight SD score (SDS) and the most recent 
BMI SDS. After internal validation, the area under the 
receiver operating characteristic curve ranged from 0.65 
(prediction at age 3 years) to 0.73 (prediction at age 5–6 
years).
Conclusions This prediction model may help to monitor 
the risk of developing high blood pressure in childhood 
which may allow for early targeted primordial prevention 
of cardiovascular disease.
IntrODuCtIOn 
In recent decades, the prevalence of child-
hood high blood pressure has increased to 
4%–5%, largely driven by the growing prev-
alence of childhood overweight and obesity.1 
Childhood high blood pressure is usually 
asymptomatic until complications occur, but 
may have adverse consequences for later 
cardiovascular health,1 partly through early 
adverse vascular changes and partly through 
tracking of childhood blood pressure levels 
into adulthood.2 Childhood high blood pres-
sure has been associated with atherosclerosis 
in autopsy studies,1 3 4 and with unfavourable 
changes in markers of subclinical atheroscle-
rosis in adulthood, such as increased carotid 
intima-media thickness and coronary artery 
calcification, independently of adulthood 
blood pressure.5 6 Although blood pressure 
does not track as strongly from childhood into 
adulthood as other cardiovascular risk factors 
such as body fat and cholesterol,7 longitudinal 
studies have demonstrated that childhood 
high blood pressure is moderately predictive 
of adulthood hypertension,8 9 a well-known 
risk factor for cardiovascular disease (CVD).10 
Several medical societies have recognised 
the importance of primordial prevention 
of CVD by preventing high blood pressure 
from early in the life course onwards,11 12 for 
example, by improving nutrition, increasing 
physical activity and decreasing sedentary 
behaviour.1 11 12 Such prevention efforts 
may be targeted to children at high risk of 
developing high blood pressure. This would 
require a tool (eg, based on a prediction 
model) that accurately identifies these chil-
dren from the general population. In many 
developed countries, the general population 
of children is reached through preventive 
strengths and limitations of this study
 ► This is the first study in which a dynamic prediction 
model for childhood high blood pressure was devel-
oped, using longitudinal information on the child’s 
body mass index.
 ► The prediction model is based on predictors that are 
usually recorded or are easy to obtain in communi-
ty-based child care settings, and may in the future 
offer an opportunity for targeted primordial preven-
tion of cardiovascular disease.
 ► The outcome predicted in this study was childhood 
high blood pressure, and not childhood hyperten-
sion, which could only have been diagnosed if blood 
pressure had been measured on at least three dif-
ferent occasions.
 ► Before considering implementation of this predic-
tion model, external validation is needed, as well as 
careful evaluation of possible benefits and harms of 
targeted preventive strategies.
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child healthcare services, well-child care services or other 
forms of community-based child healthcare, where there 
might be a possibility for targeted prevention based on 
predictive risk assessments.
To apply a prediction model in community-based 
child healthcare, ideally it should be based on informa-
tion commonly recorded or easily obtainable in such a 
setting. Studies on prediction models for future high 
blood pressure applicable in childhood are scarce,8 9 13–15 
and for most models information is needed that will 
likely be difficult to obtain in community-based child 
healthcare settings, such as repeated blood pressure 
measurements or genetic information.8 9 14 15 Also, the 
potential of some of these models for early-life targeted 
prevention is limited, as they are applicable only later 
in childhood.9 13 15 Importantly, generalisation of the 
performance of these prediction models is uncertain as 
none of them were validated.
Community-based child healthcare reaches many chil-
dren from a very early age onwards and usually repeated 
consultations take place. For example, Preventive Child 
Health Care in the Netherlands reaches over 90% of 
all children, with frequent and free preventive health 
consultations from birth until the age of 18 years.16 This 
not only provides the opportunity to start with prevention 
very early in life, but the follow-up would also allow for 
updating of predictions based on new information such 
as more recent measurements of the child’s body mass 
index (BMI). This can be described as dynamic prediction.
In this study, as a part of the Prediction Of Child 
CardiOmetabolic Risk project,17 we aimed to develop a 
dynamic prediction model feasible to use in communi-
ty-based child healthcare, from birth to the age of 6 years, 
to predict high blood pressure at the age of 9–10 years.
MethODs
Participants
Data from Generation R, a population-based prospec-
tive birth cohort study, were used. Full details of the 
study design have been published elsewhere.18 Pregnant 
women with an expected delivery date between April 
2002 and January 2006, living in Rotterdam, the Neth-
erlands, at the time of birth, were eligible. Most women 
were enrolled in pregnancy, but enrolment was allowed 
until birth. During early life, growth data from Preventive 
Child Health Care centres in the area were retrieved by 
Generation R.
From the original cohort of 9749 live born children, 
8548 children were invited for the follow-up visit at the 
age of 9–10 years; 5862 of these children attended the 
research centre, of which 5488 had complete blood pres-
sure measurements. Children aged 8 or 11 years at this 
visit (n=129) were excluded. As we aimed to develop a 
prediction model for all children from the general popu-
lation, no other exclusion criteria were applied. In total, 
data of 5359 children could be analysed (figure 1).
Outcome measure
Blood pressure was measured in the research centre by 
well-trained staff at a median age of 9.73 years (range 
9.00–10.99 years). Systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) were measured in supine 
position, at the right brachial artery, using the validated 
automatic sphygmomanometer Datascope Accutorr 
Plus.19 An appropriately sized cuff was used for each 
child, with a bladder width of 40% of the arm circum-
ference and a bladder length of more than 80% of the 
arm circumference. Blood pressure was measured four 
times with 1 min intervals. For this analysis, mean SBP and 
DBP values based on the last three measurements were 
used. Gender-specific, age-specific and height-specific 
blood pressure percentiles derived from German refer-
ence values were used to define the outcome high blood 
pressure.20 These percentiles are based on the distribu-
tion of blood pressure in a non-overweight population 
of 12 199 children, that was considered representative of 
the German population, and also included children with 
a migrant background (17.1% had a two-sided migrant 
background, most commonly Turkish or Russian). Height 
percentiles were comparable to the Dutch population, 
and blood pressure was measured with the same auto-
mated device as in Generation R.20 We chose to use refer-
ence values derived from a non-overweight population, 
as it is has been recognised that the increasing prevalence 
of overweight shifts the blood pressure distribution of a 
population upwards, while this is not a normal or healthy 
situation.21 High blood pressure was defined as mean SBP 
and/or DBP at or above the 95th percentile.
Candidate predictors
Based on previous studies and expert consultations, 
variables were identified that have been associated with 
childhood blood pressure, and that are usually recorded 
or would otherwise be relatively easy to obtain (eg, 
through self-reports or extracted from medical reports) 
in community-based child healthcare settings. These are 
presented in table S1 of online supplementary material 1, 
with supporting literature. To prevent overfitting of the 
prediction model, a selection from these potential candi-
date predictors was made based on (1) expected predictive 
strength based on the literature, (2) correlations between 
variables (eg, between maternal and paternal educational 
level, and maternal smoking during and after pregnancy) 
and (3) feasibility in community-based child healthcare. 
This resulted in the following candidate predictors for 
analysis: maternal prepregnancy BMI, maternal hyper-
tensive disease in pregnancy, maternal educational level, 
hypertension in biological parents, CVD in family of 
biological parents, parental smoking, child gender, child 
ethnicity, gestational age at birth, birth weight SD score 
(SDS) and repeatedly measured BMI SDS.
Maternal prepregnancy BMI was derived from a ques-
tionnaire during pregnancy. The presence of maternal 
hypertensive disease in pregnancy was based on delivery 
reports, cross-checked with hospital charts at admission 
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and the Netherlands Perinatal Registry. Diseases that were 
considered as maternal hypertensive disease in pregnancy 
were pregnancy-induced hypertension, pre-eclampsia 
and haemolysis elevated liver enzymes and low platelets 
syndrome (HELLP syndrome). Pre-existing hypertension 
was not considered as maternal hypertensive disease in 
pregnancy, unless there was superimposed pre-eclampsia 
or HELLP syndrome. Maternal educational level (highest 
level finished) was based on a questionnaire at inclusion, 
and categorised as none or primary education; secondary 
education; and higher education. Hypertension in the 
biological parents was self-reported in questionnaires at 
inclusion, and categorised as no parental hypertension 
or at least one parent with hypertension. Parents who 
reported not knowing if they had hypertension (3%–5% 
of received answers) were classified as not having hyper-
tension. Family history of CVD was also self-reported at 
inclusion, and considered positive if at least one parent 
had at least one relative (mother, father, sister, brother 
or child) with hypertension, myocardial infarction before 
Figure 1 Flow chart of study participants. BP, blood pressure.
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the age of 65 or stroke. Parental smoking was assessed 
through questionnaires during pregnancy (asking the 
partner whether he smoked in the 2 months before preg-
nancy), and the first 6 months (asking the mother whether 
she smoked at that time point). Next, parental smoking 
was categorised as none of the parents smoke or at least 
one parent smokes. Child ethnicity was based on ques-
tionnaires and determined in accordance with Statistics 
Netherlands according to country of birth of the child’s 
parents: if one parent was born outside the Netherlands, 
that country was used to determine the child’s ethnicity, 
and if both parents were born outside the Netherlands, 
the country of birth of the mother was used to determine 
the child’s ethnicity.22 Categories were created by consid-
ering (1) studies on the association between childhood 
high blood pressure and ethnicity in the Netherlands, 
and (2) large ethnic groups in the Netherlands.22–24 Child 
ethnicity was categorised as Western (including Dutch, 
other European, western American, western Asian, 
Oceanian), Turkish, Moroccan, Surinamese and Other 
non-western (including Cape Verdean, Dutch Antilles, 
African, non-western Asian, Indonesian, non-western 
American). Gestational age at birth in weeks and birth 
weight were based on delivery reports. Birth weight SDS, 
Table 1 Description of candidate predictors for the population for analysis (n=5359)
Candidate predictors Descriptive Available data, n (%)
Parental baseline characteristics
  Maternal prepregnancy BMI (kg/m2)* 22.6 (14.4–50.2) 4038 (75.3)
  Maternal hypertensive disease in pregnancy, n (%) 306 (6.4) 4745 (88.5)
  Maternal education level 4937 (92.1)
   No education/primary education, n (%) 360 (7.3)
    Secondary education, n (%) 2070 (41.9)
    Higher education, n (%) 2507 (50.8)
  Smoking by at least one parent, n (%) 883 (42.4) 2083 (38.9)
  Hypertension in at least one biological parent, n (%) 104 (3.7) 2792 (52.1)
  CVD in family of at least one biological parent, n (%) 1885 (68.0) 2772 (51.7)
Child characteristics
  Male gender, n (%) 2627 (49.0) 5359 (100.0)
  Gestational age at birth in weeks* 40.1 (26.3–43.6) 5327 (99.4)
  Birth weight SDS† −0.07 (1.02) 5311 (99.1)
  Child ethnicity 5240 (97.8)
   Western, n (%) 3636 (69.4)
   Turkish, n (%) 328 (6.3)
   Moroccan, n (%) 258 (4.9)
   Surinamese, n (%) 366 (7.0)
   Other non-western, n (%) 652 (12.4)
  BMI SDS around 6 months† 0.54 (1.01) 3571 (66.6)
  BMI SDS around 1 year† 0.26 (1.03) 3719 (69.4)
  BMI SDS around 2 years† 0.11 (1.06) 3491 (65.1)
  BMI SDS around 3 years† 0.13 (1.05) 3355 (62.6)
  BMI SDS around 4 years† 0.17 (1.12) 2924 (54.6)
  BMI SDS at 5–6 years† 0.51 (1.06) 4705 (87.8)
  Age in months at BMI measurement around 6 months* 6.2 (5.0–10.0) 3571 (66.6)
  Age in months at BMI measurement around 1 year* 11.1 (10.0–13.0) 3719 (69.4)
  Age in months at BMI measurement around 2 years* 24.8 (23.0–29.0) 3491 (65.1)
  Age in months at BMI measurement around 3 years* 36.7 (34.8–44.0) 3355 (62.6)
  Age in months at BMI measurement around 4 years* 45.8 (44.0–52.2) 2924 (54.6)
  Age in months at BMI measurement at 5–6 years* 72.1 (60.1–84.0) 4705 (87.8)
*Median (range).
†Mean (SD).
BMI, body mass index; CVD, cardiovascular disease; SDS, SD score.
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adjusted for gestational age, was determined according to 
Niklasson et al.25 BMI was based on protocolled measure-
ments of height and weight at either a Preventive Child 
Health Care centre (0–4 years) or the Generation R 
research centre (5–6 years, median 6.0 years). BMI SDS 
values, adjusted for age and gender, were constructed 
based on Dutch reference growth curves from 2010.26
statistical analysis
The percentage of missing values for the candidate 
predictors ranged from 0% to 61%. To be able to use all 
of the observed information for each candidate predictor, 
missing values were imputed 30 times with multivariate 
imputation by chained equations27. For three candidate 
predictors based on complete information from both 
parents (parental smoking, parental hypertension and 
CVD in family), the proportions of missing values were 
high (61%, 48% and 48%, respectively). Therefore, 
we used the separate variables from each parent in the 
imputation model; for these variables the proportions 
of missing values ranged from 14%–45%. The final 
Table 2 Associations between candidate predictors and high blood pressure at the age of 9–10 years
Characteristics Univariable OR (95% CI)
Multivariable OR from final 
model (95% CI)
Baseline predictors
  Female gender 0.85 (0.63 to 1.15) –
  Child ethnicity
   Western Reference category Reference category
   Turkish 4.27 (2.76 to 6.60) 2.63 (1.59 to 4.34)
   Moroccan 1.22 (0.58 to 2.59) 0.78 (0.34 to 1.80)
   Surinamese 1.12 (0.56 to 2.21) 0.76 (0.37 to 1.56)
   Other non-western 2.11 (1.41 to 3.17) 1.67 (1.07 to 2.59)
Gestational age at birth*, 41 weeks vs 39 weeks 0.86 (0.75 to 0.98) – 
  Birth weight, +1 SDS vs −1 SDS 0.59 (0.44 to 0.80) 0.60 (0.43 to 0.83)
  Maternal prepregnancy BMI*, 25 kg/m2 vs 21 kg/m2 1.37 (1.21 to 1.55) 1.16 (1.02 to 1.33)
  Maternal hypertensive disease in pregnancy 2.64 (1.67 to 4.15) 2.43 (1.51 to 3.93)
  Maternal educational level
   No/primary education Reference category Reference category
   Secondary education 0.62 (0.38 to 1.03) 0.86 (0.50 to 1.49)
   Higher education 0.25 (0.15 to 0.42) 0.44 (0.23 to 0.81)
  Hypertension in at least one biological parent 4.27 (2.08 to 8.75) – 
  CVD in first degree relatives of at least one biological parent 1.30 (0.79 to 2.14) – 
  Smoking by at least one parent 1.48 (0.91 to 2.41) – 
Time-varying predictors
  BMI SDS +1 vs BMI SDS −1 at age 6 months 1.22 (0.96 to 1.54) 1.28 (1.02 to 1.61)
  BMI SDS +1 vs BMI SDS −1 at age 1 year 1.32 (1.05 to 1.66) 1.35 (1.08 to 1.68)
  BMI SDS +1 vs BMI SDS −1 at age 2 years 1.54 (1.23 to 1.93) 1.50 (1.20 to 1.86)
  BMI SDS +1 vs BMI SDS −1 at age 3 years 1.80 (1.42 to 2.29) 1.66 (1.32 to 2.08)
  BMI SDS +1 vs BMI SDS −1 at age 4 years 2.11 (1.63 to 2.73) 1.85 (1.45 to 2.36)
  BMI SDS +1 vs BMI SDS −1 at age 5 years 2.47 (1.85 to 3.29) 2.05 (1.56 to 2.69)
  BMI SDS +1 vs BMI SDS −1 at age 6 years 2.89 (2.09 to 3.99) 2.28 (1.68 to 3.08)
*OR is presented for a comparison between the outer values of the IQR.
BMI, body mass index; CVD, cardiovascular disease; SDS, SD score.
Table 3 Discriminative ability of the final dynamic 
prediction model when applied at different ages between 
birth and 6 years
Age Apparent AUC
For optimism 
corrected AUC
Around 6 months 0.71 0.69
Around 1 year 0.70 0.68
Around 2 years 0.69 0.67
Around 3 years 0.67 0.65
Around 4 years 0.67 0.66
At 5–6 years 0.74 0.73
AUC, area under the ROC curve.
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imputation model included all candidate predictors, the 
outcome and the following auxiliary variables: maternal 
smoking, paternal smoking, maternal hypertension, 
paternal hypertension, maternal family history of CVD, 
paternal family history of CVD, child BMI values at other 
ages between birth and 6 years, smoking in the home 
environment, family income, paternal educational level, 
paternal BMI and maternal BMI at child age 5–6 years.
First, we studied whether the BMI SDS trajectory of a 
child would predict high blood pressure better than the 
most recent BMI SDS only. We applied a two-step model 
to investigate the use of BMI SDS trajectories. In the first 
step, each child’s BMI SDS trajectory was modelled using a 
random effects model with restricted cubic splines, and in 
the second step the individual coefficients of each child’s 
trajectory were used as a predictor in a logistic regression 
model with high blood pressure as the outcome. We saw 
that, in our study, the trajectory was not of added predic-
tive value when the most recent BMI SDS and birth weight 
SDS were already included. Therefore, in the subsequent 
analysis we used only the most recent BMI SDS and not 
the BMI SDS trajectory.
Next, logistic regression analyses were performed with 
high blood pressure at age 9–10 years as the outcome, 
predicted at different ages (6 months, 1 year, 2 years, 3 
years, 4 years and 5–6 years). For each age, a backward 
stepwise selection procedure was performed, using the 
Akaike Information Criterion for predictor selection. For 
a variable with one parameter this corresponds to selec-
tion at a p value of 0.157.28 Restricted cubic splines were 
used to examine non-linearity in the association between 
birth weight SDS and high blood pressure, because not 
only low, but also high birth weight might be associated 
with high blood pressure.29 An interaction term was 
considered for birth weight SDS and the most recent 
BMI SDS value, as it was shown that a combination of 
high current BMI with low birth weight was predictive of 
higher SBP.30 Neither the splines nor the interaction term 
were of added predictive value in our study, and thus were 
not used in the final models.
As we aimed for a dynamic prediction model that could 
be applied at any age from birth until the age of 6 years, 
we first checked whether at each age the same baseline 
predictors remained in the model after backward selec-
tion. Furthermore, we checked whether the size of the 
baseline regression coefficients was similar at each age, 
and whether the coefficient for BMI SDS would increase 
with increasing age. As these conditions were satisfied, 
we developed a dynamic prediction model by including 
the selected baseline predictors and an interaction 
between BMI SDS and age. By doing so, the predictive 
value of BMI SDS was allowed to vary with the child’s age 
at measurement, while associations of the other predic-
tors were kept constant. This approach is referred to in 
the literature as dynamic logistic regression or pooled logistic 
regression,31 and reduces the need for age-specific models. 
To take into account that each child contributes to the 
model with multiple measurements of BMI SDS (ranging 
from 0 to 14 measurements), robust standard errors were 
calculated by fitting the model using generalised esti-
mating equations (GEE) with the independence correlation 
structure. GEE is usually used to deal with repeatedly 
measured outcomes, but can also be used to adjust stan-
dard errors for repeatedly measured predictors or expo-
sures, such as BMI SDS and age in our study.31 32 For this 
purpose, an independent working correlation matrix 
must be specified.32 From the GEE analysis, we obtained 
the final model with coefficients, and the estimates for 
the apparent (ie, determined before internal validation) 
discrimination at different ages.
As currently there is no R package available to internally 
validate prediction models based on GEE, we performed 
internal validation procedures on the logistic regression 
models at each age using bootstrapping. 250 random sets 
of data were generated, with the same size as the orig-
inal dataset, drawn with replacement from the original 
data. These datasets were used to estimate, for each age, 
the optimism in the quality of the prediction model. 
Compared with other internal validation techniques such 
as cross-validation, bootstrapping is better able to capture 
model uncertainty caused by variable selection methods 
such as backward selection.33 34
As performance measures we assessed, at different 
ages, the apparent area under the receiver operating 
characteristic curve (AUC) and the AUC adjusted for 
the optimism calculated with the bootstrapping proce-
dure. The AUC is a measure of discrimination of a 
prediction model, and reflects the ability of the model 
to correctly assign a higher risk to individuals who 
have the outcome compared with those who do not.34 
Next, we assessed the calibration slopes calculated in 
the bootstrap procedure which represent, at different 
ages, the ability of the model to estimate the level of 
risk accurately. It can range from 0 to 1, where 1 means 
that the model is perfectly calibrated.34 The mean of 
these calibration slopes was used to shrink the regres-
sion coefficients estimated with the GEE approach. As 
a final step, the intercept was adjusted to re-establish 
the calibration-in-the-large, so that the mean of the 
predicted risks was again in line with the mean of the 
observed risks.34 The resulting final model was applied 
in an Excel risk calculator. All analyses were performed 
in R, version 3.3.2.
Patient involvement
Outcome definition and selection of candidate predic-
tors were presented and discussed in a meeting with a 
group of stakeholders involved with our research project, 
including child healthcare professionals and a parent 
representative from a Dutch parent organisation.
results
Model development
Table 1 shows the characteristics of the 5359 included 
children, of which 150 (2.8%) were twins and 323 (6.1%) 
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were born preterm. In total, 227 children (4.2%) had 
high blood pressure at the age of 9–10 years. Predictors 
selected in the logistic regression models were: maternal 
hypertensive disease in pregnancy, maternal educational 
level, maternal prepregnancy BMI, child ethnicity, birth 
weight SDS and child BMI SDS at the specific age. These 
models are presented in table S2 of online supplemen-
tary material. The predictive value of the child’s BMI 
SDS increased with increasing age. Table 2 shows the 
ORs for the univariable and multivariable associations 
between the candidate predictors and high blood pres-
sure based on GEE. The strongest predictors were child 
age in combination with BMI SDS, maternal educational 
level and maternal prepregnancy BMI. Apparent AUCs 
for the model ranged from 0.67 to 0.74 at different ages 
(table 3).
Internal validation and final model
After correcting for optimism, AUCs at different ages 
ranged from 0.65 to 0.73 (table 3). Calibration slopes 
ranged from 0.91 to 0.94; a mean shrinkage factor of 0.92 
was applied to the coefficients of the GEE model. The 
intercept had to be adjusted with −0.23. Figure 2 shows 
the Excel risk calculator. The predicted probabilities in 
our dataset ranged from 0.2% to 53.4% (median 3.0%). 
Within children, predicted probabilities can vary at 
different ages given their BMI SDS development (figure 3 
and table 4). Table 5 shows the prevalence of high blood 
Figure 2 Screenshot of spreadsheet with risk calculations based on the dynamic prediction model. The prediction is 
calculated using the regression equation of the final prediction model, after shrinkage of the coefficients and updating of the 
intercept. Linear predictor (LP) for high BP at age 9–10 years=−3.805+0.818*maternal hypertensive disease in pregnancy-
−0.135*maternal educational level: secondary education−0.763*maternal educational level: higher education+0.035*maternal 
prepregnancy BMI+0.888*Turkish ethnicity−0.226*Moroccan ethnicity−0.256*Surinamese ethnicity+0.470*other non-western 
ethnicity−0.237*birth weight SDS−0.005*age in months at BMI measurement+0.089*BMI SDS+0.004*age in months at BMI 
measurement*BMI SDS. Probability of high BP at age 9–10 years=1/(1 + e-LP). The Excel risk calculator is available on request to 
the corresponding author. BMI, body mass index; BP, blood pressure; SDS, SD score. 
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pressure across four categories of predicted risk at the 
ages 1, 3 and 5–6 years. For example, in children with a 
predicted risk of more than 15% at the age of 5–6 years, 
the measured prevalence of high blood pressure at the 
age of 9–10 years was 24.8%.
DIsCussIOn
We developed a dynamic model to predict, for children 
from birth until the age of 6 years in the general popu-
lation, their risk of high blood pressure at the age of 
9–10 years, based on information that is relatively easy 
to obtain. The dynamic nature of the prediction model 
allows for incorporating new information on BMI SDS 
that becomes available as a child gets older, so that the 
predicted risk can be updated.
After internal validation, the discriminative ability of 
the prediction model was moderate, and highest at the 
age of 5–6 years (AUC 0.73) which can be explained by 
the higher predictive value of BMI SDS at an age closer 
to the age at outcome assessment. Although the overall 
discriminative performance was not excellent or good, 
the prediction model did allow for identification of a 
group of children at a considerably higher risk than the 
overall study population to have high blood pressure at 
the age of 9–10 years. The prediction model might there-
fore prove helpful to community-based child healthcare 
professionals, because it would allow them to objectively 
select children for targeted prevention. On the other 
hand, before considering implementation of this predic-
tion model, first external validation studies are needed, in 
order to study the generalisability of the prediction model 
and to see what adaptations to specific populations might 
be necessary to improve the performance of the model.
In line with previous studies, we found the following 
predictors for childhood high blood pressure: maternal 
hypertensive disease in pregnancy,35 36 maternal educa-
tional level,37 38 maternal prepregnancy BMI,39 child 
ethnicity,23 24 birth weight,29 30 and BMI SDS.9 13–15 Candi-
date predictors that did not improve the model were 
gestational age at birth, child gender, hypertension in the 
biological parents, CVD in the family of the biological 
parents and parental smoking, even though in previous 
studies these were associated with blood pressure in the 
child.14 40–43 One reason these predictors proved unim-
portant in our study could be that they were correlated 
with other predictors we included, for example, parental 
hypertension with maternal BMI. For parental hyper-
tension, another explanation might be that parents 
were still relatively young and therefore the prevalence 
was low. Further, the high proportions of missing values 
for parental smoking, parental hypertension and family 
history of CVD could have decreased the power to detect 
associations between these candidate predictors and 
childhood high blood pressure. A possible reason for 
the association between gender and high blood pres-
sure reported in a previous study is that in that study the 
outcome was assessed in adolescence,41 where effects of 
puberty or other adolescence-related variables may play 
a role in differentiating the risk of high blood pressure.
As blood pressure was measured in Generation R partic-
ipants at the age of 5–6 years, we have considered adding 
SBP and/or DBP at this age to the model to improve 
its discriminative ability, but decided not to, because in 
most countries routine measurement of blood pressure 
Figure 3 Predicted probabilities of high blood pressure at 
the age of 9–10 years, predicted from the age of 6 months 
to 6 years, comparing four children with different baseline 
characteristics and different BMI SDS development (as 
shown in table 4). BMI, body mass index; BP, blood pressure; 
SDS, SD score.
Table 4 Characteristics of the four children with different baseline characteristics and different BMI SDS development
Child
Maternal 
prepregnancy 
BMI (kg/m2)
Maternal 
educational 
level
Hypertensive 
disease in 
pregnancy
Birth 
weight 
SDS
Child 
ethnicity
BMI 
SDS age 
6 months
BMI 
SDS 
age 
1 year
BMI 
SDS 
age 
2 years
BMI 
SDS 
age 
3 years
BMI 
SDS 
age 
4 years
BMI 
SDS 
age 
5 years
BMI 
SDS 
age 
6 years
  1 22.6 Higher 
education
No −0.07 Western 0 0 0 0 0 0 0
  2 22.6 Higher 
education
No −0.07 Western 0 0 0 0 +1 +2 +2
  3 22.6 No/primary 
education
No −0.07 Turkish +1 +1 +1 +1 +1 +1 +1
  4 22.6 No/primary 
education
No −0.07 Turkish +1 +1 +1 +2 +2 +3 +3
BMI, body mass index; SDS, SD score.
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has not been incorporated into community-based child 
healthcare.44 45 Even though American and European 
medical societies recommend routine measurement of 
blood pressure for children from the age of 3 years,21 46 
the debate on its usefulness is still ongoing.46 47 If blood 
pressure measurement would become a standard proce-
dure in community-based child healthcare, updating the 
prediction model with information on current blood 
pressure should be considered.
This study has several strengths and limitations. First of 
all, we used data from a large prospective cohort study, 
allowing us to consider many possible candidate predic-
tors. Based on literature and expert opinion, we believe 
that we included all the most relevant candidate predic-
tors, while also taking into account that the model should 
be applicable in most community-based child healthcare 
settings. Second, we could study the change in the predic-
tive value of childhood BMI SDS, and by using pooled 
logistic regression analysis we were able to incorporate 
this information into one dynamic prediction model that 
can be applied at different ages, increasing the ease of its 
use in practice.
A possible weakness of the cohort is the loss to follow-up: 
about 40% of the children in the original cohort did not 
attend the visit at the age of 9–10 years. In general, chil-
dren remaining in the study more often had a Western 
ethnic background, and their mothers were older and 
better educated.18 Since all ethnicities and educational 
levels were still well-represented in the follow-up, we think 
it unlikely that this loss to follow-up appreciably biased 
the associations found. An important limitation of our 
study is that for some candidate predictors based on infor-
mation from both parents (parental smoking, parental 
hypertension and CVD in the family), the proportions of 
missing values were very high. Even though we included 
all available information from each individual parent 
in the imputation model, the missing values could have 
reduced the power to detect these variables as predic-
tors for high blood pressure in our model. Therefore, we 
cannot exclude that information about these variables 
in reality might be of added predictive value (and hence 
increase the performance of the model). This should 
be investigated in external validation studies with more 
complete data on these variables. Another point that 
should be noted is that we performed the internal vali-
dation of the GEE model indirectly, that is, through boot-
strapping the logistic regression models at each age, as 
there is not yet a software package available that is able 
to perform this directly on the GEE model. The results 
were stable over the different ages and standard errors 
are correct in the analyses for one time point. Therefore, 
the estimated optimism may be considered as realistic, 
although external validation is again recommended.
It should be noted that we could only measure the 
outcome as high blood pressure and not as hypertension. To 
diagnose childhood hypertension, blood pressure needs 
to be measured on three separate occasions,21 which was 
not the case in this study. Most of the children with high 
blood pressure in our cohort would not be diagnosed 
with hypertension if they had been followed up on two 
more occasions. Based on previous studies, we estimate 
that about 1 in 4 to 5 children with high blood pressure 
in our study would be diagnosed as hypertensive.41 48 
On the other hand, the high blood pressure prevalence 
in our study might be slightly underestimated, because 
blood pressure was measured in a supine position which 
tends to give lower blood pressure values than measure-
ment in a sitting position, as in the study for the refer-
ence values.20 This might have filtered out some of the 
children without true hypertension. Setting aside these 
limitations, several studies have shown that high blood 
pressure in childhood measured on only one occasion is 
associated with an increased risk of hypertension in later 
life.8 9 Therefore, extra attention to these children could 
still be warranted, although we must be aware that this 
has not yet been studied for the more recent reference 
values for high blood pressure based on non-overweight 
populations.
If external validity can be confirmed, we would 
propose that, based on this prediction model, only 
minimally intensive (and not invasive or harmful) 
strategies should be offered to high-risk children, 
Table 5 Prevalence of high blood pressure at the age of 9–10 years across four risk categories at the age of 1, 3 and 5–6 
years
Risk category
Age 1 year
n=3719*
Age 3 years
n=3355*
Age 5–6 years
n=4705*
Number of 
children, n (%)† High BP, n (%)‡
Number of 
children, n (%)† High BP, n (%)‡
Number of 
children, n (%)† High BP, n (%)‡
0%–4.9% 2845 (76.5) 73 (2.6) 2723 (81.2) 79 (2.9) 3624 (77.0) 76 (2.1)
5%–9.9% 682 (18.3) 46 (6.7) 484 (14.4) 35 (7.2) 752 (16.0) 51 (6.8)
10%–14.9% 151 (4.1) 20 (13.2) 112 (3.3) 7 (6.3) 188 (4.0) 25 (13.3)
15% or more 41 (1.1) 9 (22.0) 36 (1.1) 12 (33.3) 141 (3.0) 35 (24.8)
*Children with observed BMI SDS values around that specific age.
†Proportion of all children.
‡Proportion of children with high BP within risk category.
BMI, body mass index; BP, blood pressure; SDS, SD score.
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considering that (1) the discriminative performance is 
only moderate, (2) it concerns prediction of high blood 
pressure and not hypertension and (3) it has not yet been 
studied whether targeted interventions in this popula-
tion would be effective. As mentioned previously, the 
prediction model might be helpful to guide communi-
ty-based child healthcare professionals in better distrib-
uting their time and efforts, by identifying children that 
need relatively more attention to prevention of CVD, for 
example in the form of tailored lifestyle and nutritional 
advice,11 12 measurement of the child’s current blood 
pressure, and monitoring of blood pressure during 
follow-up. In overweight or obese children, a higher 
predicted risk could help to underline the importance 
of improving weight status. Depending on the strate-
gies to be offered, higher or lower cut-offs to define the 
high risk group might be used, and the use of multiple 
cut-offs and differentiated strategies might also be 
considered. In very young children (eg, <4 years of age) 
with a high predicted risk, it might be a strategy to wait 
for the result of the next risk assessment before starting 
with targeted prevention. Before implementation, the 
possible benefits and harms of the preferred strategies 
should be discussed. It would also be important to inves-
tigate how parents and health professionals could expe-
rience the use of such a prediction model, including 
the acceptability and effectiveness of risk communica-
tion. Lastly, if the model would be implemented in the 
future, the effects of applying the model in combina-
tion with targeted prevention on the occurrence of high 
blood pressure should be investigated in a randomised 
or cluster randomised trial.
In summary, we developed a dynamic prediction model 
to predict the development of childhood high blood 
pressure based on information that is usually recorded 
or is easy to obtain in community-based child healthcare 
practice. This can be seen as a first step towards applying 
childhood prediction models for future high blood pres-
sure in order to offer targeted primordial prevention of 
CVD.
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